WECAN Medicare Co. Ltd. of Anyang-si, Gyeonggi-do at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

WECAN Medicare Co. Ltd.

Room 606, 25, Simin-daero 248 beon-gil, Dongan-gu, 14067 Anyang-si, Gyeonggi-do
Korea, Republic
Telephone +82 70 76307633
Fax +82 303 34407633

Hall map

MEDICA 2017 hall map (Hall 16): stand F58

Fairground map

MEDICA 2017 fairground map: Hall 16

Our range of products

Product categories

  • 05  Commodities and Consumer Goods
  • 05.07  Disposable articles for surgeries

Disposable articles for surgeries

Our products

Product category: Disposable articles for surgeries


S-protector was developed to improve the combined function of metal retractor and plastic wound protector used in surgery.

Features and Strengths
Burn prevention
Prevent a stray energy burns caused by an energy device
Reduce a pressure on skin
Protect a skin edge and reduce a pressure caused by surgical device
Provide a flexible space for surgery
Retract skin softly and provide a flexible(round or oval) space for more efficient surgery
Improvement of prognosis
Reduce a pain after surgery, prevent SSI(Surgical site infection) and
minimizes a scar on a neck
S-Protector(model: T01) is optimized for Thyroid surgery and additional 6 models in various incision size will be launched continuously.

More Less

About us

Company details

Wecan Medicare is developing an innovative product to support the advancement of medical technology. Listening to the voice from hospitals,
we explore the potential needs, commercialize them and supply the new products to hospitals which can lead to the improvement of health care.
Pursuing the best quality is only meaningful and will generate a consistent benefit to patients, hospitals and the society.
It is a corporate philosophy and principle.

S-protector was developed by James Kim, the founder of Wecan Medicare with a leading surgeon in Thyroid surgery. It improved the combined function
of surgical wound protector and retractor. To make the world best product, we have prepared the PCT application, certificate of ISO 13485 and
a qualified GMP system. CE approval is scheduled by late 2016 and US FDA approval is expected by late 2017.

More Less